[Use of ultralow doses of antibodies to gamma-interferon in the treatment and prophylaxis of viral infections].
Viral infections are at present the leading cause of morbidity in the world. The clinical trials of gamma-anaferon (pediatric formulation) in the treatment and prophylaxis of a great number of viral infections (more than 20 nosological forms) due to the RNA- and DNA-containing viruses demonstrated its efficacy and safety. Gamma-anaferon is an immunomodulator with antiviral activity containing ultralow doses of antibodies to interferon. The high efficacy of anaferon and no adverse effects allowed to consider it as the drug of choice in the treatment of various viral infections including those in children under 1 year.